ConductScience.org, home

Paper · 6975347

T cell growth factor receptors. Quantitation, specificity, and biological relevance.

Robb RJ and 2 others. J Exp Med, 1981. Cited by 1,303 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. T cell growth factor receptors. Quantitation, specificity, and biological relevance. Papers, record 6975347. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6975347

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
T cell growth factor receptors. Quantitation, specificity, and biological relevance.
PubMed
Journal
J Exp Med
PubMed
Year
1981
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
1,303
iCite
Relative citation ratio, by iCite
30.2
iCite
Revised in PubMed
2020-12-15
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Robb RJR J
2Munck AA
3Smith KAK A

Source PubMed

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Interleukin-2Major topic
LymphokinesMajor topic
Animals
Binding Sites
Binding, Competitive
Cattle
Cell Line
Chemical Phenomena
Chemistry
Cytotoxicity, Immunologic
Humans
Isoelectric Focusing
Lymphocyte Activation
Methionine
Mice
Mice, Inbred Strains
Phytohemagglutinins
Rats
Time Factors

Source PubMed

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA-17323NCI NIH HHSUnited StatesR01CA017323PubMed and NIHNIH RePORTER
CA-17643NCI NIH HHSUnited StatesR01CA017643PubMed and NIHNIH RePORTER
CA-23108NCI NIH HHSUnited StatesP30CA023108PubMed and NIHNIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17,000,675Clones of killer and helper T cells: growth requirements, specificity and retention of function in long-term culture.Immunol Rev1980https://conductscience.org/library/papers/7000675PubMed
27,000,673Interleukin 2: a class of T cell growth factors.Immunol Rev1980https://conductscience.org/library/papers/7000673PubMed
36,776,414Lymphocyte activating factor promotes T-cell growth factor production by cloned murine lymphoma cells.Nature1980https://conductscience.org/library/papers/6776414PubMed
46,778,951Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line.J Exp Med1980https://conductscience.org/library/papers/6778951PubMed
57,007,369On the mechanism of ligand-induced down-regulation of insulin receptor level in the liver cell.J Biol Chem1981https://conductscience.org/library/papers/7007369PubMed
66,451,643Mechanism of T cell activation. II. Antigen- and lectin-dependent acquisition of responsiveness to TCGF is a nonmitogenic, active response of resting T cells.J Immunol1981https://conductscience.org/library/papers/6451643PubMed
76,260,804Polypeptide hormone degradation and receptor regulation are coupled to ligand internalization. A direct biochemical and morphologic demonstration.J Biol Chem1981https://conductscience.org/library/papers/6260804PubMed
86,971,398Functional and molecular characteristics of T-cell growth factor.Mol Immunol1980https://conductscience.org/library/papers/6971398PubMed
96,787,609Culture supernatants of a stimulated T-cell line have helper activity that acts synergistically with interleukin 2 in the response of B cells to antigen.Proc Natl Acad Sci U S A1981https://conductscience.org/library/papers/6787609PubMed
106,169,447A permanent human cytotoxic T-cell line with high killing capacity against a lymphoblastoid B-cell line shows preference for HLA A, B target antigens and lacks spontaneous cytotoxic activity.Cell Immunol1981https://conductscience.org/library/papers/6169447PubMed

Cited by280

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,303 citations.

PMIDTitleJournalYearIn PapersSource
41,510,098OX40L and IL-2 combination strategy for gastric cancer immunotherapy.Transl Cancer Res2025https://conductscience.org/library/papers/41510098PubMed
41,361,892Mutant IL-2-expressing mesenchymal stromal cells promote regulatory T cells proliferation and activation in collagen induced arthritis mice.Arthritis Res Ther2025https://conductscience.org/library/papers/41361892PubMed
40,680,114BLIMP1 negatively regulates IL-2 signaling in T cells.Sci Adv2025https://conductscience.org/library/papers/40680114PubMed
36,636,297Peripheral Blood Mononuclear Cell Cytokine mRNA Profiles in Acute Respiratory Infection Patients.J Glob Infect Dis2022https://conductscience.org/library/papers/36636297PubMed
35,846,741Chicken-Specific Kinome Analysis of Early Host Immune Signaling Pathways in the Cecum of Newly Hatched Chickens Infected With Salmonella enterica Serovar Enteritidis.Front Cell Infect Microbiol2022https://conductscience.org/library/papers/35846741PubMed
33,523,442Regulation of Treg Functions by the Ubiquitin Pathway.Adv Exp Med Biol2021https://conductscience.org/library/papers/33523442PubMed
31,811,270Treg cell-based therapies: challenges and perspectives.Nat Rev Immunol2020https://conductscience.org/library/papers/31811270PubMed
31,611,250Effects of interleukin-2 in immunostimulation and immunosuppression.J Exp Med2020https://conductscience.org/library/papers/31611250PubMed
30,089,912Biology and regulation of IL-2: from molecular mechanisms to human therapy.Nat Rev Immunol2018https://conductscience.org/library/papers/30089912PubMed
29,854,806Prospects of IL-2 in Cancer Immunotherapy.Biomed Res Int2018https://conductscience.org/library/papers/29854806PubMed

1 to 10 of 280

See all 280 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IL23,558PubTator's text mininghttps://conductscience.org/library/genes/3558

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6975347

GET https://conductscience.org/api/papers/v1/6975347/references?page=2